Role of β-blocker therapy in the post-myocardial infarction patient with and without left ventricular dysfunction. The post-myocardial infarction guideline committee

Reviews in Cardiovascular Medicine

Volumn 4, Issue SUPPL. 3, 2003, Pages

  Fonarow, Gregg C ^a   Abraham, William T ^a   Cannon, Christopher P ^a   Gheorghiade, Mihai ^a   Sackner Bernstein, Jonathan D ^a   Udelson, James E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ALTEPLASE; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; CLOPIDOGREL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE; EPLERENONE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; MILRINONE; PLACEBO; PROPRANOLOL; SIMVASTATIN; TIMOLOL;

ACUTE HEART INFARCTION; ALGORITHM; ARTICLE; BRADYCARDIA; CARDIOVASCULAR RISK; DEPRESSION; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FATIGUE; FOLLOW UP; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE REPERFUSION; HEART REINFARCTION; HUMAN; MORTALITY; NIGHTMARE; PRACTICE GUIDELINE; SEXUAL DYSFUNCTION;

EID: 0141840656     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ryan TJ, Antman EM, Brooks NH, et al. ACC/AHA Guidelines for the management of patients with acute myocardial infarction:1999 update; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Available at www.acc.org. Accessed June 24, 2003.
2. Smith SC Jr, Blair SN, Bonow RO, et al. AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 2001;104:1577-1579.
3. Harder S, Thurmann P, Thierolf C, et al. Prescription of cardiovascular drugs in outpatient care: a survey of outpatients in a German university hospital. Int J Clin Pharmacol Ther. 1998; 36:195-201.
4. Chen J, Marciniak TA, Radford MJ, et al. Beta-blocker therapy for secondary prevention of myocardial infarction, in elderly diabetic patients. Results from the National Cooperative Cardiovascular Project. J Am Coll Cardiol 1999;24:1388-1394.
5. Krumholz HM, Radford MJ, Wang Y, et al. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA 1998;280:623-629.
6. Marciniak TA, Ellerbeck EF, Radford MJ, et al. Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. JAMA 1998;279:1351-1357.
7. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low- risk patients after myocardial infarction. N Engl J Med. 1998;339:489-497.
8. Gheorghiade M, Goldstein S. Beta-blockers in the post-myocardial infarction patient. Circulation. 2002;106:394-398.
9. First International Study of Infarct Survival Collaborative Group. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. Lancet. 1986;2:57-66.
10. Borzak S, Gheorghiade M. Early intervenous b-blocker combined with thrombolytic therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI-2) Trial. Prog Cardiovasc Dis. 1993;26:261-266.
11. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 1981;304:801-807.
12. Beta-Blocker Heart Attack Study Group. The beta-blocker heart attack trial: JAMA. 1981;246:2073-2074.
13. Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction: II. Morbidity results. JAMA. 1983;250:2814-2819.
14. The CAPRICORN Investigators. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet. 2001;357:1385-1390.
15. Pedersen TR. Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction. N Engl J Med. 1985;313:1055-1058.
16. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335-371.
17. The MIAMI Trial Research Group. Metoprolol in acute myocardial infarction: patient population. Am J Cardiol. 1985;56:1G-57G.
18. Hjalmarson A, Elmfeldt D, Herlitz J, et al. Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomised trial. Lancet. 1981;2:823-827.
19. Soumerai SB, McLaughlin TJ, Spiegelman D, et al. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA. 1997;277:115-121.
20. Gheorghiade M, Schultz L, Tilley B, Kao, W, Goldstein S. Effects of propranolol in non-Q-wave acute myocardial infarction in the beta-blocker heart attack trial. Am J Cardiol. 1990;66:129-133.
21. Poole-Wilson PA, Swedberg K, Cleland JG, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 2003;362:7-13.
22. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial. Lancet. 1999;353:9-13.
23. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). MERIT-HF Study Group. Lancet. 1999;353:2001-2007